Projects per year
Personal profile
Education/Academic qualification
Ph. D., Doctorat, Universitat de Barcelona (UB)
Award Date: 1 Jan 1989
Degree, Llicenciat, Universitat de Barcelona (UB)
Award Date: 1 Jan 1985
Expertise related to UN Sustainable Development Goals
In 2015, UN member states agreed to 17 global Sustainable Development Goals (SDGs) to end poverty, protect the planet and ensure prosperity for all. This person’s work contributes towards the following SDG(s):
-
SDG 3 Good Health and Well-being
-
SDG 7 Affordable and Clean Energy
Fingerprint
- 1 Similar Profiles
Collaborations and top research areas from the last five years
-
Medicina Personalizada para la mejora del tratamiento de la Leucemia Mieloide Aguda: combinación de terapias de precisión con un nanoconjugado de auristatina dirigido a las células madre leucémicas
Sierra Gil, J. (Principal Investigator)
Institute of Health Carlos III (ISCIII)
1/01/25 → 31/12/27
Project: Entity with its own legal personality projects
-
Humanized nanomedicines selectively killing CXCR4+ cancer cells for Acute Myeloid Leukemia therapy
Sierra Gil, J. (Principal Investigator)
1/06/20 → 31/05/23
Project: Entity with its own legal personality projects
-
Implicación de la vía CXCR4/CXCL12/CXCR7 en la resistencia, recidiva y fenotipo de célula madre de la leucemia mieloide aguda
Sierra Gil, J. (Principal Investigator) & Brunet Mauri, S. (Investigator)
Institute of Health Carlos III (ISCIII)
1/01/18 → 31/12/20
Project: Entity with its own legal personality projects
-
Estudio post-autorización prospectivo de terapia adaptada al riesgo en la leucemia mieloide aguda y síndromes mielodisplásicos de alto riesgo: importancia del perfil genómico y de la enfermedad residu
Sierra Gil, J. (Principal Investigator) & Brunet Mauri, S. (Investigator)
Department of Health of the Catalan Government
27/03/17 → 31/12/19
Project: Entity with its own legal personality projects
-
EURopean Endeavour for Chimeric Antigen Receptor Therapies
Sierra Gil, J. (Principal Investigator)
1/09/16 → 31/12/20
Project: Entity with its own legal personality projects
-
Clinical and immunologic characteristics of nonhematologic autoimmune disorders in chronic lymphocytic leukemia
Arguello-Tomas, M., Lynton-Pons, E., Albiol, N., López Ferrer, A., Sierra, J., Moga, E. & Moreno, C., 2025, (Accepted in press) In: Cancer. 131, 24Research output: Contribution to journal › Article › Research › peer-review
Open Access -
Diverse real-life outcomes after intensive risk-adapted therapy for 1034 AML patients from the CETLAM Group
Oñate, G., Garrido, A., Arnan, M., Pomares, H., Alonso, E., Tormo, M., Díaz-Beyá, M., Vives Polo, S., Zamora, L., Sampol, A., Coll, R., Salamero, O., Cervera, M., Garcia, A., Vall-Llovera, F., Garcia-Avila, S., Bargay, J., Ortin, X., Iranzo, E. & Guijarro, F. & 4 others, , 11 Jan 2025, In: Blood Cancer Journal. 15, 1, 11 p., 4.Research output: Contribution to journal › Article › Research › peer-review
Open Access1 Link opens in a new tab Citation (Scopus) -
Outcomes with intensive treatment for acute myeloid leukemia : an analysis of two decades of data from the HARMONY Alliance
Sobas, M. A., Turki, A., Villaverde Ramiro, Á., Hernández-Sánchez, A., Martínez Elicegui, J., González, T., Melchor, R. A., Abáigar, M., Tur, L., Dall'Olio, D., Sträng, E., Tettero, J., Castellani, G., Benner, A., Döhner, K., Thiede, C., Metzeler, K. H., Haferlach, T., Damm, F. & Ayala, R. & 15 others, , 2025, In: Haematologica. 110, 5, p. 1126-1140 15 p.Research output: Contribution to journal › Article › Research › peer-review
Open Access13 Link opens in a new tab Citations (Scopus) -
Precision targeting of CXCR4+ leukemia cells by a humanized MMAE-nanoconjugate in an AML mouse model
Garcia León, A., Mendoza, J. I., Rueda, A., Alba Castellón, L., Nomdedeu Guinot, J. F., Gallardo, A., Sierra, J., Garrido Diaz, A., Vázquez, E., Villaverde, A., Mangues, R., Unzueta Elorza, U. & Casanova Rigat, I., 2025, In: Biomedicine and Pharmacotherapy. 192Research output: Contribution to journal › Article › Research › peer-review
Open Access -
Real-life outcome after failure to venetoclax and hypomethylating-based therapy for acute myeloid leukemia
Jiménez-Vicente, C., Pomares, H., Sturla, A. L., López-Guerra, M., Guijarro, F., Merchán, B., Triguero, A., Tuca, A., Oñate, G., Sierra, J., Arnan, M., Esteve Reyner, J., Díaz-Beyá, M., Arribas, I., Ramil López, G., Castaño-Díez, S., Pérez-Valencia, A. I., Martínez-Roca, A., Zugasti, I. & Cortes-Bullich, A. & 2 others, , 2025, In: Haematologica. 110, 6, p. 1402-1406 5 p.Research output: Contribution to journal › Article › Research › peer-review
Open Access2 Link opens in a new tab Citations (Scopus)